Ruxolitinib: An effective JAK1/2 inhibitor in salvage therapy of refractory chronic GVHD

Affiliation auteurs!!!! Error affiliation !!!!
TitreRuxolitinib: An effective JAK1/2 inhibitor in salvage therapy of refractory chronic GVHD
Type de publicationJournal Article
Year of Publication2019
AuteursSimonet M, Berceanu A, Daguindau E, Desbrosses Y, Deconinck E, Larosa F
JournalBONE MARROW TRANSPLANTATION
Volume54
Pagination320
Date PublishedJUL
Type of ArticleMeeting Abstract
ISSN0268-3369